Trials / Recruiting
RecruitingNCT07272200
Understanding Gene ENvironment Interaction in ALcohol-related Hepatocellular Carcinoma
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,000 (estimated)
- Sponsor
- Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Academic / Other
- Sex
- All
- Age
- 45 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
It has been estimated that alcohol causes around 40% of premature liver deaths in Europe each year, although this number is probably underestimated. Alcohol-related liver disease (ALD) is the most common cause of liver cirrhosis and liver death in Europe with a peak age of deaths occurring among individuals aged 40 to 50. Despite these findings, ALD is little studied with only 5% of all clinical trials in the field of liver disease recorded on ClinicalTrials.gov and only 5% of all publications in the same research area. Liver cancer is the second most common cause of cancer-related death (15-20% survival at 5 years) and the second most common cause of alcohol-related cancers worldwide. Like other complex diseases, ALD-HCC results from the interaction between environmental determinants and genetic variations but knowledge of gene-environment interactions is currently lacking in this area. The GENIAL project will address these needs through a comprehensive evaluation of gene-environment interactions concerning ALD-HCC.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | quantify of risk factors | the impact of risk factors and their interaction on the incidence of disease through a score that predicts HCC and select patients for whom screening is convenient. |
Timeline
- Start date
- 2023-12-01
- Primary completion
- 2026-12-31
- Completion
- 2028-12-31
- First posted
- 2025-12-09
- Last updated
- 2025-12-09
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT07272200. Inclusion in this directory is not an endorsement.